Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-13 Sale |
2021-03-15 09:17 am |
Viela Bio Inc. | VIE | Chan Mitchell Chief Financial Officer |
37,500 | $53 | $1,987,500 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-28 Exercise |
2025-04-01 8:06 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
3,167 | $0 | 9,500 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer |
62,547 | $0 | 62,547 (Direct) |
View |
| 2024-09-16 Option Award |
2024-09-18 5:04 pm |
N/A 2034-09-16 |
REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer |
348,231 | $0 | 348,231 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:56 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
34,100 | $0 | 34,100 (Direct) |
View |
| 2023-12-20 Option Award |
2023-12-21 4:01 pm |
2024-12-20 2033-12-20 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
3,334 | $0 | 3,334 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 4:23 pm |
2023-06-14 2032-06-14 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-03 8:44 pm |
N/A 2031-12-01 |
Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director |
80,000 | $0 | 80,000 (Direct) |
View |